Recro Pharma Stock Price (NASDAQ:REPH)

Add to My Stocks
$7.72 $0.07 (0.9%) REPH stock closing price Feb 21, 2017 (Closing)
Prev Close* : $7.79
Market Cap:
$96.32M
Day Low: $7.6
52 Week Low: $5.59
Open: $7.76
Volume: 65903
Day High: $7.82
52 Week High: $12.50
Dividend:
N/A

Latest Stock Market News

Latest Articles

Recro Pharma News - From Partners

REPH Stockcharts

View REPH PE ratio, PS ratio stocks charts and compare with peers.
REPH Chart
Note: Compare Recro Pharma stock price history with the index and industry peers.

Recro Pharma Valuation

PS ratio (
price to sales ratio
)
1.21
PB ratio (
price to book ratio
)
2.37

Recro Pharma Financial Ratios

Asset Turnover
0.49
Receivables Turnover
6.32
Debt to Equity
0.6

REPH Industry Peers

Company Price Change (%)
Oasmia Pharma (OASM)2.630.15 (6.05%)
Arqule (ARQL)1.290.09 (7.5%)
Catalent (CTLT)28.880.18 (0.62%)
Elite Pharma (ELTP)0.140 (0%)
Zogenix (ZGNX)10.50.3 (2.94%)
Trevena (TRVN)4.272.86 (40.11%)
Pernix Therapeutics (PTX)2.520.09 (3.45%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sucampo Pharma (SCMP)12.60.8 (6.78%)
Portola Pharma (PTLA)32.660.98 (3.09%)
Genocea Biosciences (GNCA)4.740.14 (3.04%)
Aratana Therapeutics (PETX)6.530.19 (3%)
Zogenix (ZGNX)10.50.3 (2.94%)
Nektar Therapeutics (NKTR)13.410.31 (2.37%)
Flexion Therapeutics (FLXN)19.660.43 (2.24%)
Top gainers from Medical-Drugs industry
* As of Feb 21, 2017
CompanyPriceChange (%)
BioCryst Pharma (BCRX)6.10.46 (7.01%)
CTI BioPharma (CTIC)4.460.27 (5.71%)
Ignyta (RXDX)9.10.5 (5.21%)
PTC Therapeutics (PTCT)13.50.66 (4.66%)
La Jolla Pharma (LJPC)18.090.88 (4.64%)
Cempra (CEMP)3.20.15 (4.48%)
Tetraphase Pharmaceuticals (TTPH)5.190.24 (4.42%)
Top losers from Medical-Drugs industry
* As of Feb 21, 2017

Recro Pharma Financial Statements

income statement201520142013
Net Sales Or Revenues51.95M--
Net Income3.03M-16.13M-1.95M
Total Operating Expense30.86M11.86M1.08M
view Recro Pharma Inc income statement
balance sheet201520142013
Total Assets138.69M20.37M0.85M
Total Liabilities98.34M1.44M12.93M
Shareholders Equity40.35M18.92M-12.07M
view Recro Pharma Inc balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities7.64M0.46M0.27M
Net Cash From (Used By) Operating Activities8.45M-10.86M-0.81M
Increase (Decrease) In Prop Plant And Equipment-2.41M--
view Recro Pharma Inc cashflow statement

Recro Pharma Inc Stock News - Partner Headlines

Recro Pharma Stock Message Board

Recro Pharma stock lost -0.51 %, and the last close price as of 17 Feb, 2017 is 7.79 for REPH stock. Stock price or share price can be used to find the total market value of a company. Recro Pharma market cap stands at 96.32M as of 17 Feb, 2017. Recro Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Recro Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 134839 on the last trading day, as is evident from Recro Pharma stock chart, and REPH stock quote data. Recro Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.